GSK reports positive data from Phase III gonorrhoea antibiotic trial

GSK has announced positive data from the Phase III EAGLE-1 clinical trial of gepotidacin, an investigational oral bactericidal triazaacenaphthylene antibiotic, for the treatment of uncomplicated urogenital gonorrhoea (GC) in adolescent and adult patients.